Related Experiment Video
Updated: Jul 24, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
[HGV and TTV - new hepatitis viruses]
Hepatitis G virus (HGV) and TT virus (TTV) infections were found in nearly 20% and 12% of chronic liver disease patients, respectively. Their exact role in liver disease and treatment efficacy require further investigation.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Chronic hepatic diseases (CHD) present complex etiological challenges.
- Hepatitis G virus (HGV) and TT virus (TTV) are emerging viral agents with incompletely understood roles in liver pathology.
Purpose of the Study:
- To investigate the clinical, immunological, and morphological characteristics of HGV and TTV infections in patients with CHD.
- To evaluate the effectiveness of interferon-alpha treatment in HGV-seropositive patients, particularly those with co-infections.
Main Methods:
- Analysis of 202 patients with CHD for markers of HBV, HCV, HGV, and TTV infections.
- Liver biopsy was performed on a subset of patients.
- Interferon-alpha treatment efficacy was assessed in patients with HGV and HBV/HCV co-infections.
Main Results:
- HGV RNA and TTV DNA were detected in 19.8% and 11.8% of patients, respectively.
- Biochemical and morphological changes in patients with HGV and TTV monoinfections indicated a potential role in liver disease.
- Two out of seven patients with HGV + HBV/HCV co-infections showed a positive response to interferon-alpha treatment after 3 months.
Conclusions:
- The precise contribution of HGV and TTV to the pathogenesis of chronic hepatic diseases remains uncertain.
- Further research is essential for the detection and comprehensive examination of patients infected with HGV and TTV.
- Therapeutic strategies should consider the presence of HGV RNA, TTV DNA, viral genome in hepatocytes, and histological liver changes.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
07:58Hepatitis E Virus Fluorescence Reduction Neutralization Test for Measuring Neutralizing Antibody Titers
Published on: May 22, 2026
Related Concept Videos
Viral Recombination
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Hepatitis
Genital Herpes
Viral Hepatitis I: Introduction
Inhibitors of Virion Maturation and Assembly